Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. J of Skin [Internet]. 2021 Jan. 1 [cited 2025 Apr. 19];5(1):s8. Available from: https://skin.dermsquared.com/skin/article/view/1161